Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03226730 · ClinicalTrials.gov registry record · NA
Evaluating Household Visits and Small Groups to Increase Contraception Use Among Married Adolescent Girls in Rural Niger
A NA study, sponsored by University of California, San Diego.
- Completed
- Registry status
- NA
- Development phase
- 2,898
- Enrollment target
NCT03226730: Completed NA study, sponsored by University of California, San Diego.
NCT03226730 is a NA study that has completed, run by University of California, San Diego. The registered enrollment target is 2,898 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (106% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03226730, a NA study, has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,898 participants
- Enrollment target
Study Summary
This study entails a quasi-experimental, mixed-methods (i.e., complementary quantitative and qualitative) outcome evaluation to assess the efficacy of the Reaching Married Adolescents (RMA) Interventions developed and implemented by Pathfinder International to increase contraception use and contraception use intentions among married adolescent girls ages 13-19 in three rural districts of the Dosso region of Niger. Intervention models (gender-synchronized household visits and small groups) will be tested using a randomized 4-arm outcome evaluation design; Arm 1 will receive household visits, Arm 2 will receive small groups; Arm 3 will receive household visits plus small groups, and Arm 4 will serve as the control group and will not receive any intervention. The quantitative component will consist of collecting quantitative baseline, 16-months follow-up, and 27-months survey data from randomly selected married adolescent girls (n=1200) and their husbands (n=1200) who are participating in each Arm of the study. Qualitative elements will include ethnography at two time points and semi-structured in-depth interviews half way through intervention implementation. A costing and cost effectiveness analysis will also be conducted to evaluate which intervention provides the largest gain in the primary outcomes for each dollar spent.
Primary Outcome
Change in use of effective methods of contraception (methods assessed individually)
Interventions
- BEHAVIORAL Household Visits
- BEHAVIORAL Small Groups
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,898 participants |
| Start Date | 2016-05 |
| Est. Completion | 2021-03-10 |
| Phase | NA |
What the finished NCT03226730 record still lists
NCT03226730 is an interventional study that assigns participants to a tested intervention. Its 2,898 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (106% higher).
The record links to 0 conditions, and to 2 interventions - of which Household Visits is the first listed.
NCT03226730 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03226730 about?
NCT03226730 is a clinical study titled "Evaluating Household Visits and Small Groups to Increase Contraception Use Among Married Adolescent Girls in Rural Niger". This study entails a quasi-experimental, mixed-methods (i.e., complementary quantitative and qualitative) outcome evaluation to assess the efficacy of the Reaching Married Adolescents (RMA) Interventions developed and implemented by Pathfinder International to increase contraception use and contrace...
What is the current status of trial NCT03226730?
This trial is currently completed. It is a NA study. The enrollment target is 2,898 participants. The study started on 2016-05. Estimated completion is 2021-03-10.
What interventions are being tested in trial NCT03226730?
The interventions under investigation include: Household Visits (BEHAVIORAL), Small Groups (BEHAVIORAL).
Who is sponsoring clinical trial NCT03226730?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03226730's enrollment target sits among peer trials
2,898 43rd of 2000 higher than 1,958 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05564377 · 2,900 participants · Phase 2
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
- NCT07222995 · 2,900 participants · NA
Hybrid Effectiveness-Implementation Trial to Integrate Precision Skin Cancer Risk Feedback in FQHCs
- NCT06273436 · 2,894 participants · NA
Healing, Equity, Advocacy and Respect for Mamas
- NCT05624450 · 2,870 participants · Phase 3
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia